• Englishen
  • Françaisfr
  • Claude Meunier

    événements, séminaires

    Jeudi, 12 Mai 2022 – Melissa Bowerman (Keele University, UK) – Combining bioinformatic and drug repurposing approaches to develop second-generation therapies for spinal muscular atrophy

    Spinal muscular atrophy (SMA) is a devastating childhood disease caused by loss of function of the survival motor neuron (SMN) gene, leading to the death of nerve and muscle cells. The first SMN gene replacement therapies have recently been approved…  Continue reading

    événements, séminaires

    1 Avril 2022 – Markus Heilig (Université de Linköping, Suède) – Neurobiological mechanisms of individual vulnerability to alcohol addiction-like behaviors

    Neurobiological research on alcohol addiction had grown, but no mechanistically novel medications have been approved in more than 15 years. Promising candidates have failed in development. What have we been missing? Three themes have emerged from our attempts to address…  Continue reading

    événements, séminaires

    29 Octobre 2021 – Daniel Schulz (Neuro-PSI, Université Paris-Saclay) – Studying tactile feature encoding in the somatosensory cortex for optimizing a closed-loop brain-machine interface in mice

    Tactile information is acquired and processed in the brain through concerted interactions between movement and sensation. We study neuronal processes responsible for the coding of sensorimotor information in the barrel cortex of rodents by using a comprehensive approach including electrophysiological,…  Continue reading